Skip to main content
Log in

Prognostic Value of ALP and LDH in Periampullary Carcinoma Patients Undergoing Surgery

  • Published:
Current Medical Science Aims and scope Submit manuscript

Abstract

Objective

Conversion of normal cells to cancer cells is often accompanied by abnormal synthesis of serum enzymes. Both alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) have been reported to have prognostic value in a variety of malignancies. The aim of this study was to investigate the effect of preoperative serum ALP and LDH levels on the prognosis of patients with periampullary carcinoma who underwent pancreatoduodenectomy (PD).

Methods

According to the preoperative ALP or LDH values, 856 cancer patients receiving PD treatment from January 2001 to January 2019 were divided into high-ALP group and low-ALP group or high-LDH group and low-LDH group. Statistical analysis was carried out to study the differences between the high-ALP and low-ALP groups or the high-LDH and low-LDH groups. Furthermore, the possibility of preoperative ALP or LDH as prognostic factor of periampullary carcinoma was investigated.

Results

In both the high-ALP and the high-LDH groups, the prognosis of patients with periampullary carcinoma who underwent PD was worse than that of the low-ALP and low- LDH group. Even through risk factor analysis, it was found that preoperative ALP and LDH could be independent prognostic factor for patients with periampullary carcinoma who underwent PD.

Conclusion

Preoperative ALP or LDH is an independent risk factor for periampullary carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yu MC, Chan KM, Lee CF, et al. Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence? J Gastrointest Surg, 2011,15(8):1440–1449

    Article  Google Scholar 

  2. Zhang JP, Wang HB, Lin YH, et al. Lactate Dehydrogenase Is an Important Prognostic Indicator for Hepatocellular Carcinoma after Partial Hepatectomy. Transl Oncol, 2015,8(6):497–503

    Article  Google Scholar 

  3. Maisano R, Azzarello D, Del Medico P, et al. Alkaline phosphatase levels as a prognostic factor in metastatic colorectal cancer treated with the FOLFOX 4 regimen: a monoinstitutional retrospective study. Tumori, 2011,97(1):39–42

    Article  CAS  Google Scholar 

  4. Xie Y, Wei ZB, Duan XW. Prognostic value of pretreatment serum alkaline phosphatase in nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 2014,15(8):3547–3553

    Article  Google Scholar 

  5. Sonpavde G, Pond GR, Berry WR, et al. Serum alkaline phosphatase changes predct survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy. Urol Oncol, 2012,30(5):607–613

    Article  CAS  Google Scholar 

  6. Wei XL, Zhang DS, He MM, et al. The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma. Tumour Biol, 2016,37(2):1879–1887

    Article  CAS  Google Scholar 

  7. Chen J, Sun MX, Hua YQ, et al. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis. J Cancer Res Clin Oncol, 2014,140(7):1205–1210

    Article  CAS  Google Scholar 

  8. Wang M, Zhu F, Qin R, et al. Which Is the Best Surgical Approach for the Pancreatic Cancer? A Classification of Pancreatic Cancer to Guide Operative Decisions Is Needed. Ann Surg, 2017,265(6):E81–E82

    Article  Google Scholar 

  9. Wang M, Zhang H, Zhu F, et al. Pancreaticoduodenectomy for borderline resectable pancreatic head cancer with a modified artery-first approach technique. Hepatobiliary Pancreat Dis Int, 2017,16(2):215–221

    Article  CAS  Google Scholar 

  10. Wang M, Xu S, Zhang H, et al. Imbedding pancreaticojejunostomy used in pure laparoscopic pancreaticoduodenectomy for nondilated pancreatic duct. Surg Endosc, 2017,31(4):1986–1992

    Article  Google Scholar 

  11. Baker MS, Sherman KL, Stocker SJ, et al. Using a modification of the Clavien-Dindo system accounting for readmissions and multiple interventions: defining quality for pancreaticoduodenectomy. J Surg Oncol, 2014,110(4):400–406

    Article  Google Scholar 

  12. Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery, 2017,161(3):584–591

    Article  Google Scholar 

  13. Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery, 2007,142(5):761–768

    Article  Google Scholar 

  14. Koch M, Garden OJ, Padbury R, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery, 2011,149(5):680–688

    Article  Google Scholar 

  15. Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery, 2007,142(1):20–25

    Article  Google Scholar 

  16. Jia W, Wu J, Jia H, et al. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients. PLoS One, 2015,10(11):e0143061

    Article  Google Scholar 

  17. Azab B, Bhatt VR, Phookan J, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol, 2012,19(1):217–224

    Article  Google Scholar 

  18. Wen J, Ye F, Huang X, et al. Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study. Medicine (Baltimore), 2015,94(49):e2266

    Article  Google Scholar 

  19. Krenn-Pilko S, Langsenlehner U, Thurner EM, et al. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer, 2014,110(10):2524–2530

    Article  CAS  Google Scholar 

  20. Krenn-Pilko S, Langsenlehner U, Stojakovic T, et al. An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients. Breast, 2015,24(5):667–672

    Article  Google Scholar 

  21. Tabassum U, Reddy O, Mukherjee G. Elevated serum haptoglobin is associated with clinical outcome in triplenegative breast cancer patients. Asian Pac J Cancer Prev, 2012,13(9):4541–4544

    Article  Google Scholar 

  22. Sicking I, Edlund K, Wesbuer E, et al. Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients. PLoS One, 2014,9(10):e111306

    Article  Google Scholar 

  23. Harris H. The human alkaline phosphatases: what we know and what we don't know. Clin Chim Acta, 1990,186(2):133–150

    Article  CAS  Google Scholar 

  24. Yamamoto K, Awogi T, Okuyama K, et al. Nuclear localization of alkaline phosphatase in cultured human cancer cells. Med Electron Microsc, 2003,36(1):47–51

    Article  CAS  Google Scholar 

  25. Warburg O. On the origin of cancer cells. Science, 1956,123(3191):309–314

    Article  CAS  Google Scholar 

  26. Han X, Sheng X, Jones HM, et al. Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells. J Hematol Oncol, 2015,8:2

    Article  Google Scholar 

  27. Kojima Y, Sakurada T. Increase in alkaline phosphatase activity in the liver of mice bearing Ehrlich ascites tumor. Cancer Res, 1976,36(1):23–27

    Google Scholar 

  28. Li G, Gao J, Tao YL, et al. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma. Chin J Cancer, 2012,31(4):197–206

    Article  CAS  Google Scholar 

  29. Nilsson EE, Westfall SD, McDonald C, et al. An in vivo mouse reporter gene (human secreted alkaline phosphatase) model to monitor ovarian tumor growth and response to therapeutics. Cancer Chemother Pharmacol, 2002,49(2):93–100

    Article  CAS  Google Scholar 

  30. Faloppi L, Scartozzi M, Bianconi M, et al. The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management. BMC Cancer, 2014,14:110

    Article  Google Scholar 

  31. Scartozzi M, Faloppi L, Bianconi M, et al. The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. PLoS One, 2012,7(3):e32653

    Article  CAS  Google Scholar 

  32. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol (1985), 2000,88(4):1474–1480

    Article  Google Scholar 

  33. Zha X, Wang F, Wang Y, et al. Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis. Cancer Res, 2011,71(1):13–18

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yun-hua Deng or Ren-yi Qin.

Ethics declarations

The authors declare that there is no conflict of interest regarding the publication of this article.

Additional information

This study was supported by the National Natural Science Foundation of China (No. 81772950).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dang, C., Deng, Yh. & Qin, Ry. Prognostic Value of ALP and LDH in Periampullary Carcinoma Patients Undergoing Surgery. CURR MED SCI 42, 150–158 (2022). https://doi.org/10.1007/s11596-021-2452-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-021-2452-9

Key words

Navigation